136 related articles for article (PubMed ID: 32740549)
1. Pentoxifylline and Tocopherol in the Management of Temporal Bone Osteoradionecrosis: A Case Series.
Lovin BD; Choi JS; Lindquist NR; Phan J; Gidley PW; Nader ME
Otol Neurotol; 2020 Dec; 41(10):1438-1446. PubMed ID: 32740549
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline and tocopherol for prevention of osteoradionecrosis in patients who underwent oral surgery: A clinical audit.
Lombardi N; Varoni E; Villa G; Salis A; Lodi G
Spec Care Dentist; 2023 Mar; 43(2):136-143. PubMed ID: 35895902
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline-tocopherol-clodronate combination: A novel treatment for osteoradionecrosis of the temporal bone.
Glicksman JT; Khalili S; Fung K; Parnes LS; Agrawal SK
Head Neck; 2015 Dec; 37(12):E191-3. PubMed ID: 25821165
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline and tocopherol for the treatment of osteoradionecrosis of the jaws. A systematic review.
Arqueros-Lemus M; Mariño-Recabarren D; Niklander S; Martínez-Flores R; Moraga V
Med Oral Patol Oral Cir Bucal; 2023 May; 28(3):e293-e300. PubMed ID: 36641743
[TBL] [Abstract][Full Text] [Related]
5. [Pentoxifylline and tocopherol - The importance in the treatment of osteoradionecrosis - Literature review and case report].
Marjanowski SD; Maldonado A; Schaller B; Burkhard JM
Swiss Dent J; 2021 Sep; 131(9):713-718. PubMed ID: 34472712
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of pentoxifylline/tocopherol combination in the treatment of osteoradionecrosis.
Hayashi M; Pellecer M; Chung E; Sung E
Spec Care Dentist; 2015; 35(6):268-71. PubMed ID: 26084886
[TBL] [Abstract][Full Text] [Related]
7. Management of osteoradionecrosis of the jaws with pentoxifylline-tocopherol: a systematic review of the literature and meta-analysis.
Kolokythas A; Rasmussen JT; Reardon J; Feng C
Int J Oral Maxillofac Surg; 2019 Feb; 48(2):173-180. PubMed ID: 30205911
[TBL] [Abstract][Full Text] [Related]
8. Can the prophylactic use of pentoxifylline and tocopherol before dental extractions prevent osteoradionecrosis? A systematic review.
Paiva GLA; de Campos WG; Rocha AC; Júnior CAL; Migliorati CA; Dos Santos Silva AR
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jul; 136(1):33-41. PubMed ID: 36882364
[TBL] [Abstract][Full Text] [Related]
9. Pentoxifylline, tocopherol, and sequestrectomy are effective for the management of advanced osteoradionecrosis of the jaws-a case series.
Dos Anjos RS; de Pádua Walfrido GN; de Hollanda Valente RO; Gueiros LA; Carvalho AAT; Patel P; Porter S; Leão JC; Silva IHM
Support Care Cancer; 2021 Jun; 29(6):3311-3317. PubMed ID: 33106977
[TBL] [Abstract][Full Text] [Related]
10. The use of pentoxifylline, tocopherol and clodronate in the management of osteoradionecrosis of the jaws.
Patel S; Patel N; Sassoon I; Patel V
Radiother Oncol; 2021 Mar; 156():209-216. PubMed ID: 33385466
[TBL] [Abstract][Full Text] [Related]
11. Temporal Bone Osteoradionecrosis: An 18-year, Single-Institution Experience.
Lovin BD; Hernandez M; Elms H; Choi JS; Lindquist NR; Moreno AC; Nader ME; Gidley PW
Laryngoscope; 2021 Nov; 131(11):2578-2585. PubMed ID: 34287898
[TBL] [Abstract][Full Text] [Related]
12. Tissue repair in osteoradionecrosis using pentoxifylline and tocopherol--report of three cases.
Bohn JC; Schussel JL; Stramandinoli-Zanicotti RT; Sassi LM
Oral Maxillofac Surg; 2016 Mar; 20(1):97-101. PubMed ID: 26251132
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline and tocopherol (vitamin E) with/without clodronate for the management of osteoradionecrosis: A scoping review.
Banjar A; Patel V; Abed H
Oral Dis; 2023 Jan; 29(1):29-39. PubMed ID: 34695271
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline and tocopherol in the management of patients with osteoradionecrosis, the Portsmouth experience.
McLeod NM; Pratt CA; Mellor TK; Brennan PA
Br J Oral Maxillofac Surg; 2012 Jan; 50(1):41-4. PubMed ID: 21247671
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline, tocopherol, and clodronate for the treatment of mandibular osteoradionecrosis: a systematic review.
Martos-Fernández M; Saez-Barba M; López-López J; Estrugo-Devesa A; Balibrea-Del-Castillo JM; Bescós-Atín C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):431-439. PubMed ID: 29550081
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic Use of Pentoxifylline and Tocopherol for Prevention of Osteoradionecrosis of the Jaw after Dental Extraction in Post-Radiated Oral and Oropharyngeal Cancer Patients: An Initial Case Series.
Owosho AA; DeColibus KA; Okhuaihesuyi O; Levy LC
Dent J (Basel); 2024 Mar; 12(4):. PubMed ID: 38667995
[TBL] [Abstract][Full Text] [Related]
17. Medical treatment of osteoradionecrosis of the mandible by PENTOCLO: preliminary results.
Robard L; Louis MY; Blanchard D; Babin E; Delanian S
Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Dec; 131(6):333-338. PubMed ID: 24993781
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of pentoxifylline-tocopherol-clodronate in mandibular osteoradionecrosis.
Dissard A; P Dang N; Barthelemy I; Delbet C; Puechmaille M; Depeyre A; Pereira B; Martin F; Guillemin F; Biau J; Mirafzal S; Mom T; Gilain L; Saroul N
Laryngoscope; 2020 Nov; 130(11):E559-E566. PubMed ID: 31747060
[TBL] [Abstract][Full Text] [Related]
19. Osteoradionecrosis treatment in head and neck cancer patients: An overview of systematic reviews.
Schroter GT; Stopiglia RMM; Carvalho GL; Morimoto S; Mota ME; Alves FA; Jaguar GC; Moreira MS
Spec Care Dentist; 2024; 44(3):621-635. PubMed ID: 37534945
[TBL] [Abstract][Full Text] [Related]
20. Osteoradionecrosis: a review of pathophysiology, prevention and pharmacologic management using pentoxifylline, α-tocopherol, and clodronate.
Rivero JA; Shamji O; Kolokythas A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Nov; 124(5):464-471. PubMed ID: 29103566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
